The LAMEA Hyperpigmentation Treatment Market would witness market growth of 10.7% CAGR during the forecast period (2023-2030).
The Brazil market dominated the LAMEA Hyperpigmentation Treatment Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $191.9 million by 2030. The Argentina market is showcasing a CAGR of 11.3% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 10.4% during (2023 - 2030).
There is a growing trend toward incorporating botanical and natural ingredients in hyperpigmentation treatments. Consumers increasingly seek products with plant-based extracts known for their skin-brightening properties, such as licorice root, arbutin, kojic acid, and niacinamide. Natural ingredients are perceived as gentler alternatives to certain synthetic compounds and align with the broader consumer trend toward clean and sustainable beauty. Products containing botanical extracts are often favored for their potential to address hyperpigmentation without irritating.
As individuals age, there is a heightened focus on overall skin health, leading to a proactive approach to seeking professional skincare solutions. The increased emphasis on skin health among the aging population drives the demand for hyperpigmentation treatments as individuals prioritize interventions that contribute to healthy and radiant skin.
As per the International Trade Administration, the United Arab Emirates leads the Gulf Cooperation Council in eCommerce sales, which surged by 53% in 2020 to a record $3.9 billion, or 10% of overall retail sales. The Dubai Chamber of Commerce and Industry signifies that eCommerce will develop $8 billion in sales by 2025 as the UAE region has nearly 100% internet and mobile phone penetration. Thus, due to these aspects, the hyperpigmentation treatment market will expand across the LAMEA region in upcoming years.
Based on Treatment Type, the market is segmented into Topical Agent, Photo Therapy, and Microdermabrasion. Based on End User, the market is segmented into Dermatological Clinics, Hospitals, and Others. Based on Disorder Type, the market is segmented into Melasma, Age Spot, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The Brazil market dominated the LAMEA Hyperpigmentation Treatment Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $191.9 million by 2030. The Argentina market is showcasing a CAGR of 11.3% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 10.4% during (2023 - 2030).
There is a growing trend toward incorporating botanical and natural ingredients in hyperpigmentation treatments. Consumers increasingly seek products with plant-based extracts known for their skin-brightening properties, such as licorice root, arbutin, kojic acid, and niacinamide. Natural ingredients are perceived as gentler alternatives to certain synthetic compounds and align with the broader consumer trend toward clean and sustainable beauty. Products containing botanical extracts are often favored for their potential to address hyperpigmentation without irritating.
As individuals age, there is a heightened focus on overall skin health, leading to a proactive approach to seeking professional skincare solutions. The increased emphasis on skin health among the aging population drives the demand for hyperpigmentation treatments as individuals prioritize interventions that contribute to healthy and radiant skin.
As per the International Trade Administration, the United Arab Emirates leads the Gulf Cooperation Council in eCommerce sales, which surged by 53% in 2020 to a record $3.9 billion, or 10% of overall retail sales. The Dubai Chamber of Commerce and Industry signifies that eCommerce will develop $8 billion in sales by 2025 as the UAE region has nearly 100% internet and mobile phone penetration. Thus, due to these aspects, the hyperpigmentation treatment market will expand across the LAMEA region in upcoming years.
Based on Treatment Type, the market is segmented into Topical Agent, Photo Therapy, and Microdermabrasion. Based on End User, the market is segmented into Dermatological Clinics, Hospitals, and Others. Based on Disorder Type, the market is segmented into Melasma, Age Spot, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
List of Key Companies Profiled
- Vivier Pharma Inc.
- Pierre Fabre S.A
- Aerolase
- L'Oréal S.A.
- CP Skin Health Group, Inc. (The Colgate Palmolive Company)
- Trophy Skin Products LLC
- The Alchemee LLC (Taro Pharmaceutical Industries Ltd.)
- Episciences, Inc.
- The Procter and Gamble Company
- Galderma S.A.
Market Report Segmentation
By Treatment Type- Topical Agent
- Photo Therapy
- Microdermabrasion
- Dermatological Clinics
- Hospitals
- Others
- Melasma
- Age Spot
- Others
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. LAMEA Hyperpigmentation Treatment Market by Treatment Type
Chapter 5. LAMEA Hyperpigmentation Treatment Market by End User
Chapter 6. LAMEA Hyperpigmentation Treatment Market by Disorder Type
Chapter 7. LAMEA Hyperpigmentation Treatment Market by Country
Chapter 8. Company Profiles
Companies Mentioned
- Vivier Pharma Inc.
- Pierre Fabre S.A
- Aerolase
- L'Oréal S.A.
- CP Skin Health Group, Inc. (The Colgate Palmolive Company)
- Trophy Skin Products LLC
- The Alchemee LLC (Taro Pharmaceutical Industries Ltd.)
- Episciences, Inc.
- The Procter and Gamble Company
- Galderma S.A.
Methodology
LOADING...
